Findings from Amrita Vishwa Vidyapeetham in the Area of Alzheimer Disease Described (Exploiting Butyrylcholinesterase Inhibitors Through a Combined 3-d Pharmacophore Modeling, Qsar, Molecular Docking, and Molecular Dynamics Investigation).

Zdroj: Genomics & Genetics Weekly; 4/28/2023, p329-329, 1p
Abstrakt: Keywords: Kochi; India; Asia; Alzheimer Disease; Amrita Vishwa Vidyapeetham; Business; Butyrylcholinesterase; Cholinesterases; Enzymes and Coenzymes; Hydrolases; Molecular Dynamics; Neurodegenerative Diseases and Conditions; Physics EN Kochi India Asia Alzheimer Disease Amrita Vishwa Vidyapeetham Business Butyrylcholinesterase Cholinesterases Enzymes and Coenzymes Hydrolases Molecular Dynamics Neurodegenerative Diseases and Conditions Physics 329 329 1 04/24/23 20230428 NES 230428 2023 APR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Researchers detail new data in Neurodegenerative Diseases and Conditions - Alzheimer Disease. Acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition are significant components of AD treatment. [Extracted from the article]
Databáze: Supplemental Index